483 Andrew Schreiber Aug 2012

483 Andrew Schreiber Aug 2012

Vashti Bocker FDA, Lynette Terry FDA$119.00 - Available Now

FDA investigators audited the Andrew Schreiber - Orange, CA, United States facility and issued 4 inspectional observations (via FDA 483) on 03 Aug 2012.

Product details

  • Category: Human Drugs
  • Number of Observations: 4
  • Inspection end: 03 Aug 2012
  • Location: Orange, United States
  • FEI: 3009168198
Add To Cart